Calcineurin inhibitor toxicity in renal allografts: Morphologic clues from protocol biopsies

Indian Journal of Pathology and Microbiology

Volumn 53, Issue 4, 2010, Pages 651-657

  Sharma, Alok ^a   Jain, Sumeet ^a   Gupta, Ruchika ^a   Guleria, Sandeep ^a   Agarwal, Sanjay ^a   Dinda, Amit ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Calcineurin inhibitor toxicity; protocol biopsy; renal biopsy

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

ADULT; ARTERIOLE; ARTICLE; ATROPHY; CELL VACUOLE; CONTROLLED STUDY; FEMALE; GLOMERULOSCLEROSIS; GLOMERULUS; HISTOLOGY; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; HYPERPLASIA; JUXTAGLOMERULAR APPARATUS; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ATROPHY; KIDNEY TUBULE CELL; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NEPHROTOXICITY; SMOOTH MUSCLE FIBER; TUBULAR MICROCALCINOSIS;

ADULT; BIOPSY; CALCINEURIN; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 78149389645     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.72015     Document Type: Article

References (31)

1. Liptak P, Ivanyi B. Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts. Nat Clin Pract Nephrol 2006;2:398-404. (Pubitemid 44034190)
2. Kambham N, Nagarajan S, Shah S, Li L, Salvatierra O, Sarwal MM. A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies. Clin J Am Soc Nephrol 2007;2:135-42.
3. Serón D, Moreso F, Bover J, Condom E, Gil-Vernet S, Cañas C, et al. Early protocol renal allograft biopsies and graft outcome. Kidney Int 1997;51:310-6.
4. Mengel M, Chapman JR, Cosio FG, Cavaille-Coll MW, Haller H, Halloran PF, et al. Protocol biopsies in renal transplantation: Insights into patient management and pathogenesis. Am J Transplant 2007;7:512-7.
5. Rush DN, Nickerson P, Jeffery JR, McKenna RM, Grimm PC, Gough J. Protocol biopsies in renal transplantation: research tool or clinically useful? Curr Opin Nephrol Hypertens 1998;7:691-4.
6. Rush D. Can protocol biopsy better inform our choices in renal transplantation? Transplant Proc 2009;41:S6-8.
7. Varma M, Guleria S, Gupta S, Dinda AK, Agarwal SK, Mahajan S, et al. Significance of protocol biopsies in living related renal transplant recipients. Transplant Proc 2006;38:2016-7.
8. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007;7:518-26.
9. Andreoni KA, Brayman KL, Guidinger MK, Sommers CM, Sung RS. Kidney and pancreas transplantation in the United States, 1996-2005. Am J Transplant 2007;7:1359-75.
10. Solz K,Vincenti F, Ronald SF. Histopathologic findings from 2-year protocol biopsies from a U.S multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: A report of the FK506 Kidney Transplant Study Group. Transplantation 1998;66:1736-40.
11. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Chapman JR, Allen RD. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation 2004;78:557-65.
12. Laftavi MR, Stephan R, Stefanick B, Kohli R, Dagher F, Applegate M, et al. Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety. Surgery 2005;137: 364-71.
13. Abbas TM, Wafa EW, Bakr MA, Refaie AF, Sheashaa HA, Elagroudy AE, et al. Histologic and clinical findings in living donor allografts with long-term stable function. Am J Nephrol 2006;26:491-6.
14. Kurtkoti J, Sakhuja V, Sud K, Minz M, Nada R, Kohli HS, et al. The utility of 1- and 3-month protocol biopsies on renal allograft function: A randomized controlled study. Am J Transplant 2008;8:317-23.
15. Kim JY, Suh KS. Light microscopic and electron microscopic features of cyclosporine nephrotoxicity in rats. J Korean Med Sci 1995;10:352-9.
16. Legendre C, Thervet E, Page B, Percheron A, Noel LH, Kreis H. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993;342:248-9.
17. Randhawa PS, Saad RS, Jordan M, Scantlebury V, Vivas C, Shapiro R. Clinical significance of renal biopsies showing concurrent acute rejection and tacrolimus-associated tubular vacuolization. Transplantation 1999;67:85-9.
18. Heyman SN, Brezis M, Reubinoff CA, Greenfeld Z, Lechene C, Epstein FH, et al. Acute renal failure with selective medullary injury in the rat. J Clin Invest 1988;82:401-12.
19. Kyo M, Gudat F, Dalquen P, Fujimoto N, Ichikawa Y, Fukunishi T, et al. Differential diagnosis of kidney transplant rejection and cyclosporine nephrotoxicity by urine cytology. Transplant Proc 1992;24:1388-90.
20. Mihatsch MJ, Gudat F, Ryffel B, Thiel G. Cyclosporine nephropathy. In: Tisher CC, Brenner BM, editors. Renal Pathology with Clinical and Functional Correlations. 2nd ed. Philadelphia: Lippincott Williams and Wilkins; 1994. p. 1641.
21. Ponticelli C, Banfi G. Thrombotic microangiopathy after kidney transplantation. Transpl Int 2006;19:789-94.
22. Naesens M, Kuypers DR, Sarwal M. Calcineurin Inhibitor Nephrotoxicity. Clin J Am Soc Nephrol 2009;4:481-508.
23. Collins BS, Davis CL, Marsh CL, McVicar JP, Perkins JD, Alpers CE. Reversible cyclosporine arteriolopathy. Transplantation 1992;54:732-4.
24. Morozumi K, Thiel G, Albert FW, Banfi G, Gudat F, Mihatsch MJ. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts. Clin Nephrol 1992;38:1-8.
25. Savoldi S, Scolari F, Sandrini S, Scaini P, Sacchi G, Tardanico R, et al. Cyclosporine chronic nephrotoxicity: histologic follow-up at 6 and 18 months after renal transplantation. Transplant Proc 1988;20:777-84.
26. Strøm EH, Thiel G, Mihatsch MJ. Prevalence of cyclosporine- associated arteriolopathy in renal transplant biopsies from 1981 to 1992. Transplant Proc 1994;26:2585-7.
27. Lopez-Ongil S, Saura M, Rodriguez-Puyol D, Rodriguez-Puyol M, Lamas S. Regulation of endothelial NO synthase expression by cyclosporin A in bovine aortic endothelialcells. Am J Physiol 1996;271:H1072-8.
28. Ozdemir BH, Ozdemir FN, Demirhan B, Haberal M. TGF-beta1 expression in renal allograft rejection and cyclosporine A toxicity. Transplantation 2005;80:1681-5.
29. Young BA, Burdmann EA, Johnson RJ, Andoh T, Bennett WM, Couser WG, et al. Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy. Kidney Int 1995;48:431-8.
30. Kurtz A, Della BR, Kuhn K. Cyclosporine A enhances rennin secretion and production in isolated juxtaglomerular cells. Kidney Int 1988;33:947-53.
31. Bohle A, Christensen J, Meyer DS, Laberke HG, Strauch M. Juxtaglomerular apparatus of the human kidney: Correlation between structure and function. Kidney Int 1982;12:S18-23.